Comparison of Array-based Comparative Genomic Hybridization with Gene Expression-based Regional Expression Biases to Identify Genetic Abnormalities in Hepatocellular Carcinoma

Overview

Journal BMC Genomics

Publisher Biomed Central

Specialty Genetics

Date 2005 May 11

PMID 15882461

Citations 17

Authors

Kyle A Furge

Karl J Dykema

Coral Ho

Xin Chen

Affiliations

Soon will be listed here.

Abstract

Background: Regional expression biases (REBs) are genetic intervals where gene expression is coordinately changed. For example, if a region of the genome is amplified, often the majority of genes that map within the amplified region show increased expression when compared to genes located in cytogenetically normal regions. As such, REBs have the potential to act as surrogates for cytogenetic data traditionally obtained using molecular technologies such as comparative genomic hybridization. However as REBs are identified using transcriptional information, detection of REBs may also identify local transcriptional abnormalities produced by both genetic and epigenetic mechanisms.

Results: REBs were identified from a set of hepatocellular carcinoma (HCC) gene expression profiles using a multiple span moving binomial test and compared to genetic abnormalities identified using array-based comparative genomic hybridization (aCGH). In the majority of cases, REBs overlapped genetic abnormalities as determined by aCGH. For example, both methods identified narrow regions of frequent amplification on chromosome 1p and narrow regions of frequent deletion on 17q. In a minority of cases, REBs were identified in regions not determined to be abnormal via other cytogenetic technologies. Specifically, expression biases reflective of cell proliferation were frequently identified on chromosome 6p21-23.

Conclusion: Identification of REBs using a multiple span moving binomial test produced reasonable approximations of underlying cytogenetic abnormalities. However, caution should be used when attributing REBs identified on chromosome 6p to cytogenetic events in rapidly proliferating cells.

Citing Articles

Pancancer Analysis of the Oncogenic and Prognostic Role of : A Potential Target for Carcinogenesis and Survival.

Liu Q, Xie R, Li Y Int J Mol Sci. 2022; 23(17).

PMID: 36077008 PMC: 9455868. DOI: 10.3390/ijms23179611.

Rapid and accurate detection of mutations in colorectal cancers using the isothermal-based optical sensor for companion diagnostics.

Jin C, Yeom S, Koo B, Lee T, Lee J, Shin Y Oncotarget. 2017; 8(48):83860-83871.

PMID: 29137388 PMC: 5663560. DOI: 10.18632/oncotarget.20038.

Non-invasive Analysis of Genomic Copy Number Variation in Patients with Hepatocellular Carcinoma by Next Generation DNA Sequencing.

Xu H, Zhu X, Xu Z, Hu Y, Bo S, Xing T J Cancer. 2015; 6(3):247-53.

PMID: 25663942 PMC: 4317760. DOI: 10.7150/jca.10747.

Identification of drivers from cancer genome diversity in hepatocellular carcinoma.

Takai A, Dang H, Wang X Int J Mol Sci. 2014; 15(6):11142-60.

PMID: 24955791 PMC: 4100204. DOI: 10.3390/ijms150611142.

RNA sequencing reveals upregulation of RUNX1-RUNX1T1 gene signatures in clear cell renal cell carcinoma.

Xiong Z, Yu H, Ding Y, Feng C, Wei H, Tao S Biomed Res Int. 2014; 2014:450621.

PMID: 24783204 PMC: 3982423. DOI: 10.1155/2014/450621.

References

Pollack J, Sorlie T, Perou C, Rees C, Jeffrey S, Lonning P . Microarray analysis reveals a major direct role of DNA copy number alteration in the transcriptional program of human breast tumors. Proc Natl Acad Sci U S A. 2002; 99(20):12963-8. PMC: 130569. DOI: 10.1073/pnas.162471999. View

Chen X, Cheung S, So S, Fan S, Barry C, Higgins J . Gene expression patterns in human liver cancers. Mol Biol Cell. 2002; 13(6):1929-39. PMC: 117615. DOI: 10.1091/mbc.02-02-0023. View

Harding M, Arden K, Gildea J, Gildea J, Perlman E, Viars C . Functional genomic comparison of lineage-related human bladder cancer cell lines with differing tumorigenic and metastatic potentials by spectral karyotyping, comparative genomic hybridization, and a novel method of positional expression profiling. Cancer Res. 2002; 62(23):6981-9. View

Clamp M, Andrews D, Barker D, Bevan P, Cameron G, Chen Y . Ensembl 2002: accommodating comparative genomics. Nucleic Acids Res. 2003; 31(1):38-42. PMC: 165530. DOI: 10.1093/nar/gkg083. View

Crawley J, Furge K . Identification of frequent cytogenetic aberrations in hepatocellular carcinoma using gene-expression microarray data. Genome Biol. 2003; 3(12):RESEARCH0075. PMC: 151177. DOI: 10.1186/gb-2002-3-12-research0075. View

Higgins J, Shinghal R, Gill H, Reese J, Terris M, Cohen R . Gene expression patterns in renal cell carcinoma assessed by complementary DNA microarray. Am J Pathol. 2003; 162(3):925-32. PMC: 1868114. DOI: 10.1016/S0002-9440(10)63887-4. View

Mao R, Zielke C, Zielke H, Pevsner J . Global up-regulation of chromosome 21 gene expression in the developing Down syndrome brain. Genomics. 2003; 81(5):457-67. DOI: 10.1016/s0888-7543(03)00035-1. View

Veltman J, Fridlyand J, Pejavar S, Olshen A, Korkola J, DeVries S . Array-based comparative genomic hybridization for genome-wide screening of DNA copy number in bladder tumors. Cancer Res. 2003; 63(11):2872-80. View

Fischer G, Ibrahim S, Brockmann G, Pahnke J, Bartocci E, Thiesen H . Expressionview: visualization of quantitative trait loci and gene-expression data in Ensembl. Genome Biol. 2003; 4(11):R77. PMC: 329133. DOI: 10.1186/gb-2003-4-11-r77. View

10.

Husing J, Zeschnigk M, Boes T, Jockel K . Combining DNA expression with positional information to detect functional silencing of chromosomal regions. Bioinformatics. 2003; 19(18):2335-42. DOI: 10.1093/bioinformatics/btg314. View

11.

van Eijk R, Oosting J, Sieben N, van Wezel T, Cleton-Jansen A . Visualization of regional gene expression biases by microarray data sorting. Biotechniques. 2004; 36(4):592-4, 596. DOI: 10.2144/04364BM05. View

12.

Kim J, Chung H, Park C, Park W, Kim J . ChromoViz: multimodal visualization of gene expression data onto chromosomes using scalable vector graphics. Bioinformatics. 2004; 20(7):1191-2. DOI: 10.1093/bioinformatics/bth052. View

13.

Masayesva B, Ha P, Garrett-Mayer E, Pilkington T, Mao R, Pevsner J . Gene expression alterations over large chromosomal regions in cancers include multiple genes unrelated to malignant progression. Proc Natl Acad Sci U S A. 2004; 101(23):8715-20. PMC: 423261. DOI: 10.1073/pnas.0400027101. View

14.

Beissbarth T, Speed T . GOstat: find statistically overrepresented Gene Ontologies within a group of genes. Bioinformatics. 2004; 20(9):1464-5. DOI: 10.1093/bioinformatics/bth088. View

15.

Furge K, Lucas K, Takahashi M, Sugimura J, Kort E, Kanayama H . Robust classification of renal cell carcinoma based on gene expression data and predicted cytogenetic profiles. Cancer Res. 2004; 64(12):4117-21. DOI: 10.1158/0008-5472.CAN-04-0534. View

16.

Brantley-Sieders D, Chen J . Eph receptor tyrosine kinases in angiogenesis: from development to disease. Angiogenesis. 2004; 7(1):17-28. DOI: 10.1023/B:AGEN.0000037340.33788.87. View

17.

Gilbert N, Boyle S, Fiegler H, Woodfine K, Carter N, Bickmore W . Chromatin architecture of the human genome: gene-rich domains are enriched in open chromatin fibers. Cell. 2004; 118(5):555-66. DOI: 10.1016/j.cell.2004.08.011. View

18.

Lindvall C, Furge K, Bjorkholm M, Guo X, Haab B, Blennow E . Combined genetic and transcriptional profiling of acute myeloid leukemia with normal and complex karyotypes. Haematologica. 2004; 89(9):1072-81. View

19.

Gentleman R, Carey V, Bates D, Bolstad B, Dettling M, Dudoit S . Bioconductor: open software development for computational biology and bioinformatics. Genome Biol. 2004; 5(10):R80. PMC: 545600. DOI: 10.1186/gb-2004-5-10-r80. View

20.

Semple C . Deep genomics in shallow times: the finished sequence of human chromosomes 13 and 19. Eur J Hum Genet. 2004; 12(11):875-6. DOI: 10.1038/sj.ejhg.5201254. View